A Maryland Senate committee has unanimously approved a bill to create a psychedelics task force to study and make recommendations on a possible regulatory framework for substances such as psilocybin and DMT. It would be charged specifically with ensuring “broad, equitable and affordable access to psychedelic substances” in the state.
With a key legislative deadline fast approaching, the Senate Finance Committee on Friday moved to replace the language of the legislation from Sen. Brian Feldman (D) with that of an amended companion version that cleared the full House of Delegates this week, and then advanced it on a voice vote.
“Right off the bat, I have to say some of you may look at the bill and you’re gonna see the name ‘psychedelic substances,’ and many of you might immediately tune out,” Feldman said at an earlier hearing the committee held to consider the legislation on Thursday. “Similar to 10 years ago when I was here and the topic of medical cannabis came up, and it was a similar kind of thing like, ‘What the heck? What are we thinking? What are we doing? And of course now we’ve got 40 states in the United States that have legalized medical
Read full article on Marijuana Moment
